Contact
Please use this form to send email to PR contact of this press release:
NexImmune and The Leukemia & Lymphoma Society enter partnership for the development of AIM ACT™ in AML patients
TO:
Please use this form to send email to PR contact of this press release:
NexImmune and The Leukemia & Lymphoma Society enter partnership for the development of AIM ACT™ in AML patients
TO: